Paclitaxel and gemcitabine vs. carboplatin and gemcitabine.  A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)

Reviewer: S. Jack Wei, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 14 de mayo del 2005

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016